Peng Luo

413 total citations
32 papers, 236 citations indexed

About

Peng Luo is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peng Luo has authored 32 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 10 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peng Luo's work include Sarcoma Diagnosis and Treatment (8 papers), Reconstructive Surgery and Microvascular Techniques (5 papers) and Vascular Tumors and Angiosarcomas (3 papers). Peng Luo is often cited by papers focused on Sarcoma Diagnosis and Treatment (8 papers), Reconstructive Surgery and Microvascular Techniques (5 papers) and Vascular Tumors and Angiosarcomas (3 papers). Peng Luo collaborates with scholars based in China. Peng Luo's co-authors include Chunmeng Wang, Wangjun Yan, Biqiang Zheng, Weiluo Cai, Zhengwang Sun, Shiqi Chen, Hui Chen, Shiqi Chen, Wending Huang and Yingqiang Shi and has published in prestigious journals such as European Journal of Medicinal Chemistry, Molecular and Cellular Endocrinology and BMC Cancer.

In The Last Decade

Peng Luo

27 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Luo China 9 116 91 61 52 52 32 236
Kevin K. Chang United States 6 202 1.7× 103 1.1× 48 0.8× 36 0.7× 82 1.6× 12 274
Dorian Yarih García-Ortega Mexico 8 127 1.1× 83 0.9× 36 0.6× 35 0.7× 40 0.8× 37 215
Zhonghua Xu China 7 222 1.9× 51 0.6× 31 0.5× 69 1.3× 123 2.4× 21 347
Fabrizio Scognamillo Italy 10 51 0.4× 121 1.3× 56 0.9× 34 0.7× 106 2.0× 35 300
Jianmin Song China 6 237 2.0× 252 2.8× 44 0.7× 70 1.3× 101 1.9× 16 362
Shervin V. Oskouei United States 10 194 1.7× 107 1.2× 18 0.3× 36 0.7× 95 1.8× 19 290
Ryo Shibuya Japan 10 164 1.4× 162 1.8× 44 0.7× 56 1.1× 32 0.6× 16 328
Sarah Burrow Canada 10 141 1.2× 90 1.0× 102 1.7× 17 0.3× 98 1.9× 18 386
Wanlim Kim South Korea 11 155 1.3× 102 1.1× 44 0.7× 29 0.6× 102 2.0× 41 313
Alexandra Meurgey France 10 156 1.3× 63 0.7× 32 0.5× 23 0.4× 18 0.3× 29 250

Countries citing papers authored by Peng Luo

Since Specialization
Citations

This map shows the geographic impact of Peng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Luo more than expected).

Fields of papers citing papers by Peng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Luo. The network helps show where Peng Luo may publish in the future.

Co-authorship network of co-authors of Peng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Luo. A scholar is included among the top collaborators of Peng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Luo. Peng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Kun, Peng Luo, Caihua Li, et al.. (2025). Design, synthesis, and biological evaluation of novel PROTACs based on unnatural dipeptide CRBN ligands. European Journal of Medicinal Chemistry. 303. 118387–118387. 1 indexed citations
2.
Wang, Yufeng, Changjing Zuo, Xinyuan Li, et al.. (2025). Unlocking the potential of immune checkpoint inhibitors in advanced cervical cancer: a meta-analysis and systematic review. BMC Cancer. 25(1). 863–863.
3.
Zhang, Xian, Yingying Zhang, Guangheng Xiang, et al.. (2024). Comprehensive management of degloving soft tissue injuries of the extremity: A 12-year retrospective study. Injury. 55(12). 111939–111939. 1 indexed citations
4.
Lei, Yanhua, Qing Tang, Caihua Li, et al.. (2024). Design, synthesis and biological evaluation of new RNF126-based p300/CBP degraders. Bioorganic Chemistry. 148. 107427–107427. 2 indexed citations
5.
Lu, Tianyu, et al.. (2023). Microbiome and function alterations in the gastric mucosa of asymptomatic patients with Helicobacter pylori infection. Helicobacter. 28(3). e12965–e12965. 6 indexed citations
6.
Cai, Leyi, Xian Zhang, Yingying Zhang, et al.. (2023). Reconstruction of Composite Soft Tissue Defect in the Distal Finger Using Partial Toenail Flap Transfer. Orthopaedic Surgery. 15(10). 2716–2723. 4 indexed citations
7.
Chen, Hong, Kai Xia, Weijun Huang, et al.. (2021). Autologous transplantation of thecal stem cells restores ovarian function in nonhuman primates. Cell Discovery. 7(1). 75–75. 12 indexed citations
8.
Wu, Zhiqiang, Wei Sun, Peng Luo, et al.. (2021). CCNDBP1, a Prognostic Marker Regulated by DNA Methylation, Inhibits Aggressive Behavior in Dedifferentiated Liposarcoma via Repressing Epithelial Mesenchymal Transition. Frontiers in Oncology. 11. 687012–687012. 5 indexed citations
9.
Xie, Qigen, Kai Xia, Xiangping Li, et al.. (2021). Application of the Mathieu combined tunnel technique for repairing glans dehiscence after failed hypospadias repair. Asian Journal of Andrology. 24(3). 311–316. 4 indexed citations
10.
Feng, Xin, Kai Xia, Qiong Ke, et al.. (2020). Transplantation of encapsulated human Leydig-like cells: A novel option for the treatment of testosterone deficiency. Molecular and Cellular Endocrinology. 519. 111039–111039. 4 indexed citations
11.
Chen, Shiqi, Peng Luo, Biqiang Zheng, et al.. (2019). Prognostic analysis of surgically treated clear cell sarcoma: an analysis of a rare tumor from a single center. International Journal of Clinical Oncology. 24(12). 1605–1611. 9 indexed citations
12.
Xu, Yu, Yan Yan, Peng Luo, et al.. (2019). Common Nevus and Skin Cutaneous Melanoma: Prognostic Genes Identified by Gene Co-Expression Network Analysis. Genes. 10(10). 747–747. 14 indexed citations
13.
Huang, Wending, Peng Luo, Weiluo Cai, et al.. (2019). <p>Undifferentiated Pleomorphic Sarcoma: Long-Term Follow-Up from a Large Institution</p>. Cancer Management and Research. Volume 11. 10001–10009. 38 indexed citations
14.
15.
Chen, Shiqi, et al.. (2019). Liposarcoma: Advances in Cellular and Molecular Genetics Alterations and Corresponding Clinical Treatment. Journal of Cancer. 11(1). 100–107. 27 indexed citations
16.
Wu, Zhiqiang, Hao Zhang, Zhengwang Sun, et al.. (2019). Knockdown of Kinesin Family 15 Inhibits Osteosarcoma through Suppressing Cell Proliferation and Promoting Cell Apoptosis. Chemotherapy. 64(4). 187–196. 8 indexed citations
17.
Luo, Peng, Weiluo Cai, Shiqi Chen, et al.. (2018). Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection. Cancer Management and Research. Volume 10. 4727–4734. 10 indexed citations
18.
Zhu, Huiyan, et al.. (2018). Apatinib mesylate tablet in the treatment of advanced malignant melanoma. OncoTargets and Therapy. Volume 11. 5333–5338. 9 indexed citations
19.
Luo, Peng, et al.. (2016). Femoral Intertrochanteric Fracture With Spontaneous Lumbar Hernia: A Case Report. Trauma Monthly. 21(5). e25132–e25132. 2 indexed citations
20.
Luo, Peng, et al.. (2015). [Treatment of low lumbar degenerative disease with unilateral pedicle screw combined with contralateral percutaneous transfacet screws fixation].. PubMed. 28(4). 318–22. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin K. Chang Breakdown of academic impact, for papers by Dorian Yarih García-Ortega Breakdown of academic impact, for papers by Zhonghua Xu Breakdown of academic impact, for papers by Fabrizio Scognamillo Breakdown of academic impact, for papers by Jianmin Song Breakdown of academic impact, for papers by Shervin V. Oskouei Breakdown of academic impact, for papers by Ryo Shibuya Breakdown of academic impact, for papers by Sarah Burrow Breakdown of academic impact, for papers by Wanlim Kim Breakdown of academic impact, for papers by Alexandra Meurgey
Rankless by CCL
2026